Can an enzyme cofactor be a factor in malignant progression?

Cancer Biology and Therapy

Volumn 10, Issue 11, 2010, Pages 1112-1114

  Richardson, Adam D ^a   Moscow, Jeffrey A ^b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Hif1; Hypoxia; Metabolism; SLC19A3; Thiamine; THTR2; Vitamin B1

Indexed keywords

ACETYL COENZYME A; CARRIER PROTEIN; ENZYME; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; OXOGLUTARATE DEHYDROGENASE; PROTEIN KINASE B; PROTEIN SLC19A3; PYRUVATE DEHYDROGENASE; THIAMINE; TRANSKETOLASE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CITRIC ACID CYCLE; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; HUMAN; HYPOXIA; NOTE; PROTEIN FUNCTION;

CELL HYPOXIA; COENZYMES; DISEASE PROGRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MEMBRANE TRANSPORT PROTEINS; NEOPLASMS; THIAMINE;

EID: 78649836690     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.11.14061     Document Type: Note

References (20)

1. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-33.
2. Zhao R, Gao F, Goldman ID. Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells. Am J Physiol Cell Physiol 2002; 282:1512-7.
3. Zhao R, Gao F, Wang Y, Diaz GA, Gelb BD, Goldman ID. Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem 2001; 276:1114-8.
4. Bettendorff L. Thiamine homeostasis in neuroblastoma cells. Neurochem Int 1995; 26:295-302.
5. Bettendorff L, Goessens G, Sluse F. Reversibility of thiamine deficiency-induced partial necrosis and mitochondrialuncoupling by addition of thiamine to neuroblastoma cell suspensions. Mol Cell Biochem 1997; 174:121-4.
6. Bettendorff L, Goessens G, Sluse F, Wins P, Bureau M, Laschet J, et al. Thiamine deficiency in cultured neuroblastoma cells: effect on mitochondrial function and peripheral benzodiazepine receptors. J Neurochem 1995; 64:2013-21.
7. Bettendorff L, Grandfils C, De Rycker C, Schoffeniels E. Determination of thiamine and its phosphate esters in human blood serum at femtomole levels. J Chromatogr 1986; 382:297-302. (Pubitemid 17194734)
8. Bettendorff L, Grandfils C, Wins P, Schoffeniels E. Thiamine triphosphatase in the membranes of the main electric organ of Electrophorus electricus: substrate-enzyme interactions. J Neurochem 1989; 53:738-46.
9. Bettendorff L, Wins P. Mechanism of thiamine transport in neuroblastoma cells. J Biol Chem 1994; 269:14379-85.
10. Sweet R, Paul A, Zastre J. Hypoxia Induced Upregulation and Function of the Thiamine Transporter, SLC19A3 in a Breast Cancer Cell Line. Cancer Biol Ther 2010; 1101-11.
11. Liu S, Huang H, Lu X, Golinski M, Comesse S, Watt D, et al. Downregulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis. Mol Cancer Res 2003; 1:665-73.
12. Liu S, Stromberg A, Tai HH, Moscow JA. Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells. Mol Cancer Res 2004; 2:477-87.
13. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3:177-85.
14. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003; 23:9361-74. (Pubitemid 37499822)
15. Langbein S, Zerilli M, Zur Hausen A, Staiger W, Rensch-Boschert K, Lukan N, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 2006; 94:578-85.
16. Krockenberger M, Honig A, Rieger L, Coy JF, Sutterlin M, Kapp M, et al. Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int J Gynecol Cancer 2007; 17:101-6.
17. Mitschke L, Parthier C, Schroder-Tittmann K, Coy J, Ludtke S, Tittmann K. The crystal structure of human transketolase and new insights into its mode of action. J Biol Chem 285:31559-70.
18. Haseloff RF, Krause E, Bigl M, Mikoteit K, Stanimirovic D, Blasig IE. Differential protein expression in brain capillary endothelial cells induced by hypoxia and posthypoxic reoxygenation. Proteomics 2006; 6:1803-9.
19. Sun W, Liu Y, Glazer CA, Shao C, Bhan S, Demokan S, et al. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res 16:857-66.
20. Zhao F, Mancuso A, Bui TV, Tong X, Gruber JJ, Swider CR, et al. Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Oncogene 29:2962-72.